by Simran Chahal | Mar 30, 2022 | Business, Health, News
14-3-3η: A Critical Mass of Data A recent systematic literature review describes a substantive body of evidence for 14-3-3η’s clinically important role along the whole continuum of rheumatoid arthritis and autoimmune patient care.Key Statements:14-3-3η helps to...
by Simran Chahal | Nov 11, 2021 | Business, Health, News
Recent journal publications are fortifying the clinically important role of the 14-3-3η blood test along the whole continuum of RA and autoimmune patient care. From RA meta-analysis data through to 14-3-3η expression in juvenile idiopathic arthritis and secondary...
by Simran Chahal | Jul 30, 2020 | Business, Health, News
Do you have a patient with Systemic Lupus Erythematosus (SLE) that you suspect may also have Sjögren’s Syndrome (SS)? With shared clinical and serological features, overlapping SS with SLE is a comorbidity that is often challenging to identify to promptly assist...
by George Ciuciureanu | Nov 5, 2019 | News
Dynacare Launches JOINTstat® Testing in Canada Augurex is pleased to announce the launch of JOINTstat (14-3-3ƞ) testing services through Dynacare, one of Canada’s largest and most established health solution companies with a dedicated mission to support healthy lives...
by Simran Chahal | Apr 3, 2019 | Business, News
Augurex is very proud to announce that Natalie Dakers, Chair of our Board of Directors, has been awarded the 2019 Milton Wong Award. Natalie’s award is well-deserved given her outstanding leadership and notable impact on the Life Sciences ecosystem, which Augurex has...
by Simran Chahal | Jan 1, 2019 | Business, Health, News
USPTO Awards Patent for Citrullinated 14-3-3: Expanding Augurex’s Portfolio in the Diagnosis of Rheumatoid Arthritis (RA) On November 20th, 2018 the US Patent and Trademark Office (USPTO) awarded patent number 10,132,806 entitled “Antigens Derived From...
